Results 141 to 150 of about 3,185,179 (238)

Bronchodilator reversibility testing in morbidly obese non-smokers: a comparative study- few concerns. [PDF]

BMC Pulm Med
Balan D, Shetty MR, Mohan MK.
europepmc   +1 more source

Current Evidence on the Usefulness of Potential Therapies in the Prevention of COPD Exacerbations: Beyond the Use of Bronchodilator Therapy and Inhaled Corticosteroids. [PDF]

Open Respir Arch
Figueira-Gonçalves JM, Callejas-González FJ, Golpe R, Máiz-Carro L, Marín-Oto M, de Miguel-Díez J, Loscertales-Vacas GS, Tordera-Mora JM, Hurtado-Fuentes Á.   +8 more
europepmc   +1 more source

Glycopyrronium inhalation, bronchodilator reversibility assessment, and defining asthma: A new paradigm. [PDF]

Lung India
Bhattacharyya P, Sen S, Ghosh S.
europepmc   +1 more source

ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD. [PDF]

Eur Respir J
Wade RC, Martinez FJ, Criner GJ, Tombs L, Lipson DA, Halpin DMG, Han MK, Singh D, Wise RA, Kalhan R, Dransfield MT.   +10 more
europepmc   +1 more source

Identification of MicroRNAs in children with increased asthma bronchodilator usage in genetics of asthma in Costa Rica Study. [PDF]

Pediatr Pulmonol
Wong R, Desai B, Sharma R, Srivastava U, Kho AT, Weiss ST, Celedón JC, McGeachie MJ, Tantisira K.   +8 more
europepmc   +1 more source

Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial. [PDF]

Nat Commun
Zhou Y, Wu F, Shi Z, Cao J, Tian J, Yao W, Wei L, Li F, Cai S, Shen Y, Wang Z, Zhang H, Chen Y, Fu Y, He Z, Chang C, Jiang Y, Chen S, Yang C, Yu S, Tian H, Cheng Q, Zhao Z, Ying Y, Zhou Y, Liu S, Deng Z, Huang P, Zhang Y, Luo X, Zhao H, Gui J, Lai W, Hu G, Liu C, Su L, Liu Z, Huang J, Zhao D, Zhong N, Ran P, China N-acetylcysteine in Mild-to-moderate COPD Study Group.   +41 more
europepmc   +1 more source

Twenty years of inhaled insulin: promise, setbacks, and future directions. [PDF]

EXCLI J
Gaddas M, Ben Saida I, Ben Saad H.
europepmc   +1 more source

Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents. [PDF]

Pharmaceutics
D'Agnano V, Perrotta F, Fomez R, Carrozzo VM, Schiattarella A, Sanduzzi Zamparelli S, Pagliaro R, Bianco A, Mariniello DF.   +8 more
europepmc   +1 more source

CFAP43 variant in persistent respiratory symptoms after hematopoietic cell transplantation. [PDF]

Hum Genome Var
Nagasawa S, Nishimura T, Yamada A, Kamimura S, Ishimura M, Moritake H.   +5 more
europepmc   +1 more source